We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Ventana and Barco Alliance to Revolutionize Digital Pathology Viewing Experience

By LabMedica International staff writers
Posted on 14 Jun 2013
Ventana Medical Systems, Inc. More...
(VMSI; Tucson, AZ, USA), member of the Roche Group, has announced the signing of a worldwide agreement with healthcare imaging expert Barco, Inc. (Kortrijk Belgium) to provide Barco's leading diagnostic and clinical review display systems for use with Ventana’s Virtuoso image and workflow management system, offering a turnkey solution that provides consistent whole slide image viewing with efficiency.

"This agreement represents a fusion of digital pathology visualization technologies from two of the industry's most innovative healthcare leaders," said Steve Burnell, PhD, digital pathology and workflow lifecycle leader at VMSI; "The Ventana integrated digital pathology solution, now including Barco's products, will appeal to the most discerning practitioners."

The advantages of medical grade displays over commercial off-the-shelf monitors include enhanced contrast; color accuracy and sharpness; prolonged image stability over time; and the ability to calibrate the screen for optimal viewing. Barco's Coronis Fusion 4MP DL diagnostic color display and MDRC-2124 wide-screen clinical monitor offer these capabilities and more for precise, high confidence viewing. Barco's system supports effortless and precise panning and zooming on whole slide images. Moreover, the display system includes Barco's MediCal Awe, an automated, real-time calibration system that provides high image quality and consistency across the screen for the life of the display.

Ventana’s Virtuoso is a comprehensive, web-based software application. From initial slide scanning to complete reporting, the Virtuoso software supports multiple users, enabling remote viewing of slide images, online collaboration sessions with other pathologists, and slide sharing of images. Its intuitive user interfaces are customized for the workflow of pathologists, histotechnologists, lab administrators, and clinicians, enhancing efficiencies throughout the process.

"We are delighted to forge this exciting alliance with Ventana as we solidify our ongoing commitment to the digital pathology market," said Mike Sklar, vice president sales, healthcare, at Barco, North America; "Ventana offers all the ingredients for a successful partnership: in-depth market knowledge, a passion for technology excellence, and unwavering dedication to customer needs—all of the tenets that Barco upholds."

Related Links:
Ventana Medical Systems
Medical Imaging Systems at Barco, Inc.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.